Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|February 25, 2017
Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft miceTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.
International Journal of Cancer|May 30, 2013
New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysisTsuyoshi Takahashi, Satoshi Serada, Maiko Ako, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 8, 2025
Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cellsTakashi Yokouchi, Tsuyoshi Takahashi, Toshirou Nishida, et al.
International Journal of Cancer|February 8, 2023
Combination of pimitespib (TAS-116) with sunitinib is an effective therapy for imatinib-resistant gastrointestinal stromal tumorsRyugo Teranishi, Tsuyoshi Takahashi, Yuuki Obata, et al.
Molecular Plant|October 15, 2009
Xyloglucan for generating tensile stress to bend tree stemKei'ichi Baba, Yong Woo Park, Tomomi Kaku, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 29, 2009
Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis miceTetsuya Nomura, Yasuhiro Abe, Haruhiko Kamada, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 7, 2018
SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signalingTakahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, et al.
British Journal of Cancer|July 17, 2015
Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosisRie Natatsuka, Tsuyoshi Takahashi, Satoshi Serada, et al.
British Journal of Cancer|March 11, 2020
Anti-glypican-1 antibody-drug conjugate is a potential therapy against pancreatic cancerTakahiko Nishigaki, Tsuyoshi Takahashi, Satoshi Serada, et al.
British Journal of Cancer|June 17, 2016
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinomaHisashi Hara, Tsuyoshi Takahashi, Satoshi Serada, et al.
Pageof 13